The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Probably alot of nervous investors deciding not to invest in CMET until they get the placing out of the way. I know people will say they are funded for the year, well that doesn't mean lot in AIM.
Seen it so many times, like AAOG for example, that kept saying it was all nonsense about the 10p placing rumour, when the price hit 17p. Tom Winfred called it and it turned out to be true. Obviously the price started to go south, so they did the placing at 10p!
As previously stated, the EIA approval will probably be delayed. This is AIM and 99% of the time they over promise and under deliver. BOD have gone very quiet, so I will wait it out until a sub 10p price can be bought, bu the end of June.
I learnt from years on AIM that you don't always have to jump into a share hoping for good news. Deadlines are rarely met on AIM and I see this going the same way. Obviously it is better to buy in low and get better multiples when this does rise.